News

"Answers Unlocked" will provide patients with information about genetic testing and empower them to talk to their doctor about genetic testing and see...

AKF launches the Rare Kidney Disease Action Network (RKDAN), a new effort that will play a vital role in ensuring that the voices of people fighting rare kidney...

Roundtable discussion and reception held ahead of nation's first ever AMKD Awareness Day on April 30

Campaign aims to increase understanding and recognition of AMKD

AKF announces sponsorship from Novartis Pharmaceuticals Corporation for education and awareness campaigns for two rare kidney diseases: complement 3 glomerulopa...

As a part of its Unknown Causes of Kidney Disease (UCKD) Project, AKF surveyed health care providers to understand opportunities and barriers in diagnosing chro...

AKF is pleased to announce that Vertex Pharmaceuticals Inc. is providing support for its education and awareness campaign about the apolipoprotein L1 (APOL1) ge...

Researchers from Stanford University School of Medicine, Brigham and Women's Hospital and Massachusetts General Hospital will study health disparities, ren...